Binary and ternary copper(II) complexes of a new Schiff base ligand derived from 4-acetyl-5,6-diphenyl-3(2H)-pyridazinone: Synthesis, spectral, thermal, antimicrobial and antitumor studies

The development of biocompatible fluorescent materials based on CdII (d10) systems for cytotoxic application and latent fingerprint detection under UV illumination has not yet been studied that thoroughly. In this sense, this work presents production of novel and dual nature pure Cd (II) phosphor complex based on ρ‐dimethylaminobenzaldehyde thiosemicarbazone ligand (H‐DMABTS). The structural characterization confirms that the ligand which acts as monoanionic bidentate through NS donor sites, forming mononuclear complex formulates as: [Cd (DMABTS)2(C2H5OH)2] where, DMABTS = anionic form of ρ‐dimethylaminobenzaldehyde thiosemicarbazone. TEM analysis shows that Cd (II) complex has sheet like shape in micro scale. Moreover, the Cd (II) complex was dispersed into silica host. Photoluminescence emission and lifetime of H‐DMABTS ligand, Cd (II) complex and Cd (II) complex dispersied into silica were measured. Cd (II) complex is intensive luminescent with impressive visual emission under UV excitation. All fluorescent materials were tested for their in vitro cytotoxicity against HepG‐2 cell line. The Cd (II) phosphor complex shows higher activity (IC50 = 0.005 μM) than other prepared materials and different standard antitumor drugs. Furthermore, the Cd (II) phosphor complex has a lower toxicity value (LD50 = 130 mg/Kg) relative to the standard cis‐platin (LD50 = 13.5 mg/Kg). Moreover, latent prints details, including their characteristic three levels, have been clearly identified from various forensic substrates (non‐porous, semi‐porous, porous) using Cd (II) phosphor complex.

Section: Resultssupporting

confidence: 86%

Synthesis and Fundamental Characterization of Diverse Properties of Biocompatible Cd (II) Phosphor Complex for Cytotoxic Activity and Latent Fingerprint Detection

Fouad

2020

“…The electronic spectrum of complex 1 exhibits an absorption band at 590 nm, which may be due to the 2 E g → 2 T 2g transition corresponding to a distorted octahedral geometry . The electronic spectrum of Cu II ‐complex/NaY shows one band about 600 nm, which may be attributed to 2 B 1g → 2 A 1g transition, indicating a square‐planar configuration …”

Section: Resultsmentioning

confidence: 98%

New less toxic zeolite‐encapsulated Cu(II) complex nanomaterial for dual applications in biomedical field and wastewater remediation

Khalil

Kishk

EL-Mekkawi

et al. 2019

Self Cite

A new dual‐functional Cu(II) complex and its nanohybrid form encapsulated into NaY zeolite cavities were synthesized. The synthesized compounds were characterized using elemental analyses, X‐ray fluorescence, infrared, 1H NMR, electronic, electron spin resonance and mass spectra, powder X‐ray diffraction, surface area and transmission electron microscopy in addition to conductivity and magnetic susceptibility measurements. The encapsulated Cu(II) complex was catalytically tested for degradation of industrial wastewater. The decolorization and mineralization results indicate that the Cu(II) complex encapsulated into zeolite host is an effective heterogeneous catalyst for real industrial wastewater remediation. In addition, both free and encapsulated Cu(II) complexes were tested as anti‐microbial and anti‐tumour agents. The results show that the Cu(II) complex encapsulated into zeolite has a high activity (IC50 = 14.4 μg ml−1). The results of in vivo toxicity experiments indicate that the Cu(II) complex encapsulated into zeolite is a less toxic biocompatible material (LD50 = 1245 mg kg−1). The catalytic properties, cytotoxicity and toxicity of the new nanohybrid Cu(II) complex encapsulated into zeolite make it a promising eco‐friendly and biocompatible material for water remediation and biomedical applications.

“…The shape of the ESR signals is consistent with the octahedral geometry of the Fe (III) complex . On the other hand, the spectrum of complex 2 displays one broad band with g = 2.05 and the profile of the spectrum reveals the square planar geometry of the Cu (II) complex …”

Section: Resultsmentioning

confidence: 99%

Synthesis, spectroscopic, biological, and theoretical studies of new complexes from (E)‐3‐(2‐(5, 6‐ diphenyl‐1,2,4‐ triazin‐3‐ yl)hydrazono)butan‐2‐ one oxime

Samy

2020

Self Cite

New mononuclear Fe (III), Cu (II), Ag (I), ZrO ( IV) and UO2(VI) complexes were synthesized by the reaction of metal ions with (E)‐3‐(2‐(5, 6‐ diphenyl‐1,2,4‐ triazin‐3‐ yl)hydrazono)butan‐2‐ one oxime. The structures of the metal complexes were characterized using analytical, spectral (infrared, electronic, 1H NMR, electron spin resonance (ESR), and mass), magnetic moment, molar conductance, thermal gravimetric analysis, and powder X‐ray diffraction (XRD) measurements. All complexes have octahedral geometries except the Cu (II) complex, which has square planar geometry, and the UO2(VI) complex, in which the coordination number is seven. The ligand acts as a (neutral, monoanionic or dianionic) tridentate with N2O coordinating sites: N‐azomethine, N‐triazine, and O‐oxime. Fluorescence spectral studies were carried out in solid state and in dimethylformamide (DMF). The kinetic parameters of the thermal decomposition stages were calculated using Coats–Redfern equations. The morphological structures of the ligand and some complexes were determined using XRD. The molecular orbital calculations were carried out for the ligand and metal complexes using the Hyperchem 7.52 program on the basis of the PM3 level. The antimicrobial activities of the ligand and its complexes were investigated towards the microorganisms S. aureus and B. subtilis as Gram‐positive bacteria, S. typhimurium and E. coli as Gram‐negative bacteria, C. albicans, and A. fumigatus. The ligand and its complexes showed antitumor activity against Hep G‐2 cell lines, where Cu (II) and Ag (I) complexes seem to be promising as they showed IC50 values that are lower than and comparable to that of the antitumor drug doxorubicin.